Exposure to new environments and diseases can put travellers at an increased risk of serious illness. Travel vaccines against diseases such as hepatitis A and B, rabies, typhoid and cholera

Market Analysis and Insights: Global and China Travel Vaccines Market
This report focuses on global and China Travel Vaccines market.
In 2020, the global Travel Vaccines market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Travel Vaccines market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Travel Vaccines Scope and Market Size
Travel Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Travel Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Travel Vaccines market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Cholera
Rabies Vaccine
Hepatitis
Typhoid

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen